DELL CHILDRENS MEDICAL CENTER
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $2.9M
- Transactions
- 998
- Companies
- 32
- Average per transaction
- $2,878
Who reported the payments
| Edwards Lifesciences | $648,072 |
| CSL Behring | $444,709 |
| Portola Pharmaceuticals, LLC | $330,534 |
| Mallinckrodt Enterprises LLC | $201,955 |
| Regeneron | $167,458 |
| Pfizer | $153,321 |
| Mallinckrodt Hospital Products Inc. | $147,038 |
| Vertex | $132,152 |
| E.r. Squibb & Sons, L.L.C. | $105,665 |
| Zevra Therapeutics Inc | $71,098 |
| Neuropace, Inc. | $69,196 |
| GW Research Limited | $65,336 |
| Atricure, Inc. | $60,633 |
| Amgen | $55,621 |
| AbbVie | $53,377 |
| Jazz Pharmaceuticals Inc. | $49,279 |
| Novartis | $26,689 |
| Olympus America Inc. | $23,911 |
| Janssen Research & Development, LLC | $15,575 |
| Merck | $11,889 |
| Aimmune Therapeutics, Inc. | $6,653 |
| Baxter Healthcare | $6,091 |
| Kls-martin L.p. | $5,922 |
| Esperion Therapeutics, Inc. | $3,218 |
| Incyte Corporation | $3,056 |
| Applied Medical Technology Inc | $3,000 |
| Zimmer Biomet | $2,845 |
| KARL Storz Endoscopy-america | $2,820 |
| Artivion, Inc. | $2,488 |
| Gilead | $2,000 |
| Stryker | $509 |
| Aesculap, Inc. | $85 |